Hip implant under the microscope: 5-Year safety study launched
NCT ID NCT05524363
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is tracking 120 people who received a HYPE SCS hip stem during total hip replacement. Researchers will monitor how long the implant lasts, how satisfied patients are, and any complications over 5 years. The goal is to confirm the device is safe and works as intended in everyday medical practice.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- HYPE SCS femoral stem (hip implant device)
- What this could lead to
- If successful, this study will confirm that the HYPE SCS hip stem is safe and works well for up to 5 years after surgery.
- What could go wrong
- This is an observational study, not a test of a new treatment. It only follows routine care, so it cannot prove the implant is better than others. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
120 people
The number who actually took part.
- Started
-
Oct 2020
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Recruitment of adults patients representing 120 hips operated between 2020 and 2022 (8 patients have been implanted at both hips).
- Ages
-
18 years and older
- Sex
-
Anyone
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients over 18 years old. * Patients covered by health insurance system * Patients requiring a total hip arthroplasty, implanted swith a femoral stem SCS associated to NOVAE Sunfit TH acetabular cup Exclusion Criteria: * Patient who expressed opposition to participation in the study and to the use of his personal data * Patient unable to understand surgeon's instructions and meet follow-ups requirements * Patient presenting a contraindication indicated in the IFU of both implantsw * Patient presenting a contraindication to have an X-ray * Patients implanted with a femoral stem SCS associated to NOVAE Sunfit TH acetabular cup, in context of off-label use
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hip arthropathy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre hospitalier " J. Monod ",
Flers-en-Escrebieux, 61104, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple grip test predict joint replacement recovery?
- Can your own cells ease osteoarthritis pain?
- Can a less invasive hip surgery speed up recovery?
- Virtual reality headsets could replace painkillers after hip surgery
- New hip implant tested for safer fracture repair
- Hip implant tracked for a decade: will it last?